176 related articles for article (PubMed ID: 21773699)
1. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth.
Xu H; Liu YL; Yang YM; Dong XS
Int J Colorectal Dis; 2012 Jan; 27(1):21-30. PubMed ID: 21773699
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
Huang L; Hu C; Cao H; Wu X; Wang R; Lu H; Li H; Chen H
Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360
[TBL] [Abstract][Full Text] [Related]
3. Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells.
Lv L; Xiao XY; Gu ZH; Zeng FQ; Huang LQ; Jiang GS
Mol Cell Biochem; 2011 Jan; 346(1-2):11-21. PubMed ID: 20824490
[TBL] [Abstract][Full Text] [Related]
4. USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway.
Liu YL; Jiang SX; Yang YM; Xu H; Liu JL; Wang XS
Cell Biochem Biophys; 2012 Jan; 62(1):229-35. PubMed ID: 21928107
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
[TBL] [Abstract][Full Text] [Related]
6. Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest.
Ling SB; Sun DG; Tang B; Guo C; Zhang Y; Liang R; Wang LM
Cell Mol Biol (Noisy-le-grand); 2012 Dec; 58 Suppl():OL1803-8. PubMed ID: 23217440
[TBL] [Abstract][Full Text] [Related]
7. USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer.
Kosinsky RL; Helms M; Zerche M; Wohn L; Dyas A; Prokakis E; Kazerouni ZB; Bedi U; Wegwitz F; Johnsen SA
Cell Death Dis; 2019 Dec; 10(12):911. PubMed ID: 31801945
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.
Xu G; Cai J; Wang L; Jiang L; Huang J; Hu R; Ding F
Exp Cell Res; 2018 Jan; 362(2):268-278. PubMed ID: 29174979
[TBL] [Abstract][Full Text] [Related]
9. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
[TBL] [Abstract][Full Text] [Related]
10. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.
Ling S; Li J; Shan Q; Dai H; Lu D; Wen X; Song P; Xie H; Zhou L; Liu J; Xu X; Zheng S
Mol Oncol; 2017 Jun; 11(6):682-695. PubMed ID: 28417539
[TBL] [Abstract][Full Text] [Related]
11. USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.
Ding F; Bao C; Tian Y; Xiao H; Wang M; Xie X; Hu F; Mei J
Int J Mol Sci; 2014 Dec; 16(1):307-20. PubMed ID: 25547493
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Ubiquitin-Specific Protease 22 Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Osteosarcoma Cells.
Zhang D; Jiang F; Wang X; Li G
Oncol Res; 2017 May; 25(5):743-751. PubMed ID: 27983930
[TBL] [Abstract][Full Text] [Related]
13. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
[TBL] [Abstract][Full Text] [Related]
14. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
Gennaro VJ; Stanek TJ; Peck AR; Sun Y; Wang F; Qie S; Knudsen KE; Rui H; Butt T; Diehl JA; McMahon SB
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9298-E9307. PubMed ID: 30224477
[TBL] [Abstract][Full Text] [Related]
15. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
16. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cells.
Liang J; Zhang XL; Li S; Xie S; Wang WF; Yu RT
Cancer Biomark; 2018; 23(3):381-389. PubMed ID: 30223389
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1.
Ao N; Liu Y; Feng H; Bian X; Li Z; Gu B; Zhao X; Liu Y
Cell Physiol Biochem; 2014; 33(6):1863-75. PubMed ID: 24969755
[TBL] [Abstract][Full Text] [Related]
20. MiR-30e-5p inhibits proliferation and metastasis of nasopharyngeal carcinoma cells by target-ing USP22.
Ma YX; Zhang H; Li XH; Liu YH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6342-6349. PubMed ID: 30338802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]